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Lactate released by inflammatory bone marrow
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Neutrophils provide first line of host defense against bacterial infections utilizing glycolysis
for their effector functions. How glycolysis and its major byproduct lactate are triggered in
bone marrow (BM) neutrophils and their contribution to neutrophil mobilization in acute
inflammation is not clear. Here we report that bacterial lipopolysaccharides (LPS) or Sal-
monella Typhimurium triggers lactate release by increasing glycolysis, NADPH-oxidase-
mediated reactive oxygen species and HIF-1α levels in BM neutrophils. Increased release of
BM lactate preferentially promotes neutrophil mobilization by reducing endothelial VE-
Cadherin expression, increasing BM vascular permeability via endothelial lactate-receptor
GPR81 signaling. GPR81−/− mice mobilize reduced levels of neutrophils in response to LPS,
unless rescued by VE-Cadherin disrupting antibodies. Lactate administration also induces
release of the BM neutrophil mobilizers G-CSF, CXCL1 and CXCL2, indicating that this
metabolite drives neutrophil mobilization via multiple pathways. Our study reveals a meta-
bolic crosstalk between lactate-producing neutrophils and BM endothelium, which controls
neutrophil mobilization under bacterial infection.
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Innate immune neutrophils are the first cells to be mobilizedand recruited from the bone marrow (BM), against bacterialinfections1. During steady-state homeostasis, most murine
neutrophils reside in the BM, and only a small fraction migrate to
the circulation2,3. However, during inflammation, BM neu-
trophils are rapidly mobilized to the blood and recruited to
peripheral organs in order to eradicate the invading pathogens4,5.
Activation of pro-inflammatory signaling pathways involves sti-
mulation of metabolic pathways in immune cells as a part of host
defense responses6. These include increased oxygen consumption
during myeloid induced phagocytosis, due to activation of
NADPH oxidase (NOX) in order to generate oxygen free radi-
cals7. Furthermore, studies mimicking bacterial infection also
revealed increased glucose uptake8 and a shift to glycolysis rather
than oxidative phosphorylation, which is characteristic of pro-
inflammatory macrophages9.
While there are multiple studies concerning immune-
metabolism of macrophages, less is known about neutrophil
metabolic control during the onset of acute inflammation. Neu-
trophils are highly glycolytic with limited mitochondrial
respiration10,11. Lactate, a major byproduct of glycolysis, was
found to be released by human neutrophils12 and increased lac-
tate levels are used as a marker for detecting sepsis in
patients13,14. However, mechanistic reasoning for lactate pro-
duction by BM neutrophils and its potential role during the early
phase of acute inflammation remain elusive.
Here, we report that exposure to LPS or live Salmonella acti-
vates (within 4 h) BM neutrophils to produce and release lactate
in both NOX- and hypoxia-inducible factor-1α (HIF-1α)-
dependent manners. The metabolite lactate preferentially mobi-
lizes neutrophils by increasing BM vascular permeability upon
activation of the lactate-receptor GPR81 expressed by BM
endothelial cells. In addition, lactate also induces the release of
the neutrophil attracting chemokines CXCL1 and CXCL2, and of
the neutrophil mobilizing-cytokine granulocyte colony stimulat-
ing factor (G-CSF), which also involves GPR81-independent
mechanisms. Consequently, lactate administration increases the
defective LPS-induced mobilization of activated neutrophils in
NOX-mutated mice, further demonstrating the critical roles of
this metabolite in neutrophil mobilization during the early phase
of bacterial infection.
Results
LPS increases lactate production by BM neutrophils. Neu-
trophils are predominantly glycolytic cells that produce reactive
oxygen species (ROS) through the cytosolic enzyme NOX. This
process is essential for microbial eradication and regulation of
inflammation15,16. To better understand the metabolic con-
sequences of BM neutrophil activation during the onset of acute
inflammation, we treated wild-type (WT) mice with a low dose of
LPS to mimic acute gram-negative bacterial inflammation. Our
findings indicate that 4 h after LPS administration activated BM
neutrophils (CD11b+/Ly6Ghigh cells; Supplementary Fig. 1a)
displayed increased glucose uptake (Fig. 1a), upregulated gene
expression encoding the rate limiting glycolytic enzymes (hex-
okinase 1 (HK1) and phosphofructokinase 1 (PFKL); Fig. 1b) and
downregulated levels of the TCA cycle genes (Supplementary
Fig. 1b). Collectively, our findings suggest that BM neutrophils
activate their glycolysis with very low rates of TCA cycle and
oxidative phosphorylation during the onset of acute
inflammation.
Next, we documented high production of ROS in BM
neutrophils following LPS administration (Fig. 1c). Since ROS
was shown to activate HIF-1α in macrophages17, we tested the
impact of LPS on HIF-1α levels in BM neutrophils and found
higher percentages of HIF-1α+ neutrophils in the BM induced by
LPS exposure (Fig. 1d). Moreover, we found that BM neutrophils
express elevated levels of lactate dehydrogenase A (LDHA), a key
glycolytic enzyme involved in the conversion of pyruvate to
lactate, following systemic exposure to LPS (Fig. 1e). Notably, we
found that selective depletion of neutrophils by neutralizing Ly6G
antibodies resulted in lower levels of BM lactate (a functional
output of LDHA activity) in mice injected with LPS (Fig. 1f,
Supplementary Fig. 1c). These data were supported by the
observation that BM isolated neutrophils directly released high
amounts of lactate following in vitro LPS stimulation (Fig. 1g,
Supplementary Fig. 1d). Taken together, our results demonstrate
that LPS can directly induce glycolysis and oxidative bursts in BM
neutrophils which lead to the production and release of lactate by
these leukocytes during the early phase of acute inflammation.
However, we cannot rule out that LPS administration can also
indirectly activate BM neutrophils and drive their mobilization
via its effects on other BM cell subsets.
Lactate cellular levels are tightly balanced by monocarboxylase
transporters (MCTs)12,18. MCT1 mediates lactate influx, while
MCT4 is expressed only in glycolytic cells and mediates lactate
efflux19,20. In addition, lactate can bind and signal through its G-
protein coupled receptor GPR81 (also named hydroxycarboxylic
acid receptor 1 (HCAR1)) and activates different signaling
pathways21,22. We found that in steady state, MCT4 is highly
expressed by BM neutrophils, while low expression of MCT1 and
GPR81 was observed on the neutrophil surface (Fig. 1h,
Supplementary Fig. 1e, f). Among BM myeloid cells, we found
that MCT4 is preferentially expressed by neutrophils (LysMhigh/
Ly6Ghigh) and to a lower extent by monocytes (LysMint/Ly6Gneg)
(Supplementary Fig. 1g). Moreover, LPS administration further
upregulated MCT4 expression on BM neutrophils (Fig. 1i).
Interestingly, we found that LPS-induced glucose uptake
(Supplementary Fig. 1h) and MCT4 expression (Supplementary
Fig. 1i) also on PB neutrophils as well and not only on BM
neutrophils. In addition, LPS treatment increased the levels of
lactate (Supplementary Fig. 1j) and reduced the glucose levels in
the blood without changing the blood pH (Table 1), suggesting
that LPS-mobilized neutrophils are still glycolytic and most
probably release lactate upon reaching vascular targets within
inflamed peripheral organs to further promote their recruitment.
Taken together, our results suggest that during the acute phase of
LPS-induced inflammation, BM neutrophils uptake high amounts
of glucose and convert it to lactate via glycolysis in the cytosol.
Consequently, ROS and HIF-1α levels are increased to further
activate the glycolytic pathway to produce and to release high
levels of lactate via MCT4 (Fig. 1j).
Lactate preferentially induces BM neutrophil mobilization.
Since our results indicate that BM neutrophils produce lactate
during the onset of acute LPS-induced inflammation, we next
investigated whether exogenous administration of this metabolite
affects neutrophil mobilization from the BM, a hallmark of bac-
terial infection. Strikingly, injection of sodium lactate to WT mice
(an upper physiological concentration range, Supplementary
Fig. 2a, b) led to reduction in BM neutrophil levels within 4 h
(Fig. 2a, Supplementary Fig. 2c), accompanied by robust neu-
trophil mobilization to the peripheral blood (PB; Fig. 2b, Sup-
plementary Fig. 2d) and recruitment to the liver in a dose-
dependent manner (Fig. 2c), without changing the blood pH
(Table 1).
Notably, rapid neutrophil mobilization to the blood was
detected as early as 2 h post lactate injection (Fig. 2d). We applied
intravital two-photon laser-scanning microscopy in order to track
live neutrophil mobilization over time. We generated chimeric
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Fig. 1 LPS increases glycolysis as well as lactate production by BM neutrophils. a Flow cytometry quantitative analysis of 2-NBDG-glucose uptake by BM
neutrophils (CD11bhighLy6Ghigh cells; n= 6) 4 h following i.p. administration of LPS in vivo in wild-type (WT) mice. b Gene expression of glycolytic
enzymes in sorted BM neutrophils from WT mice following LPS treatment (n= 3, PBS; n= 5, LPS). On each box, the bottom, middle, and the top edges
indicate the 25th, 50th, and 75th percentiles, respectively. The whiskers extend to the most extreme data points. c Quantitative analysis and representative
histogram plot showing mean fluorescent intensity (MFI) of ROS production in BM neutrophils following LPS administration (n= 9). d Percentage of
HIF-1α+ neutrophils in the BM following LPS administration (n= 11). e Quantitative analysis and representative histogram plot of LDHA expression in BM
neutrophils following LPS treatment (n= 7). ***p(0.0003). f BM lactate levels in WT mice treated with PBS, LPS, or LPS followed by α-Ly6G Ab (n= 7).
g Lactate levels released from isolated BM neutrophils treated ex vivo with PBS or LPS (120 ng/ml; n= 4 mice).**p(0.0063). h MCT4, MCT1, and GPR81
(yellow) distribution on BM CD11b+ (green)/Ly6G+ (red) neutrophils visualized and quantified by ImageStream analysis. Images are from one
representative experiment out of three. Scale bar indicates 7 μm. i Quantitative analysis of MCT4 expression on BM neutrophils 4 h following LPS
administration (n= 7). j A scheme of the proposed mode of action of LPS in lactate production by BM neutrophils. Data are represented as mean ± SEM
from 3 to 4 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, Student’s two-tailed unpaired t test (a, c–e, g, i), one-way ANOVA
with Tukey’s post hoc test (f, h) or two-way ANOVA with Tukey’s post hoc test (b). See also Supplementary Fig. 1.
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mice in which hematopoietic cells from the BM of Catchup (Ly6G
tdTomato23) mice were transplanted into Sca-1 eGFP recipient
mice (Supplementary Fig. 2e), and tracked live neutrophils in the
calvarial bone (Supplementary Fig. 2f). Consistent with our flow
cytometry-based results, we observed high numbers of neutro-
phils (Ly6G positive tdTomato cells) within the superior sagittal
sinus (sinusoid endothelial Sca-1low cells24) of the calvarial BM
~3 or 4 h post lactate administration as indicated (Supplementary
Fig. 2g, h, Supplementary Movies 1 and 2, Fig. 2e, Supplementary
Fig. 2i).
Upon neutrophil activation, ROS are produced by NOX via a
robust “oxidative burst”25,26. To assess if neutrophils acquire an
activated phenotype in response to lactate, we measured ROS
production and found increased levels of ROShigh activated
neutrophils in the circulation 4 h after lactate administration
(Fig. 2f). Next, we found that the number of white blood cells
(WBCs) was reduced in the BM following lactate injection
(Supplementary Fig. 3a). In addition, despite the increase in PB
neutrophils, we detected reduction in the number of PB WBCs
(Supplementary Fig. 3a), suggesting a differential cell-specific
response. We therefore determined the effect of lactate on other
BM immune cells. Our results reveal that despite the expression
of lactate transporters MCT4 and MCT1 and lactate receptor
GPR81 on other BM immune cells (Supplementary Fig. 3b–d;
respectively), lactate administration acted preferentially on
neutrophils (LysMhigh/Ly6Ghigh cells), as we found no significant
increase in the levels of PB monocytes or lymphocytes 4 h post
lactate injection (Supplementary Fig. 3e, f; respectively). These
results suggest that in addition to the higher levels of lactate
transporters, other pro-inflammatory factors are involved in the
rapid neutrophil mobilization 4 h following lactate administra-
tion. Nevertheless, mobilization of monocytes to the circulation
was observed later, 8 h post lactate injection (Supplementary
Fig. 3g).
Finally, we examined the involvement of lactate production
and release in neutrophil mobilization during acute inflamma-
tion. LPS administration increased the levels of PB neutrophils, in
particular of activated ROShigh neutrophils (Fig. 2h–k). Pharma-
cological inhibition (Fig. 2g) of LDHA by specific inhibitors
(sodium oxamate or FX11) or inhibition of MCT4 (lactate efflux)
by α-cyano-4-hydroxycinnamic acid (CHC) markedly reduced
the levels of either neutrophils or ROShigh neutrophils in the
blood (Fig. 2h–k, respectively, see Methods for gating neutrophils
in these specific experiments). Taken together, our results suggest
that lactate preferentially induces rapid neutrophil mobilization
to the peripheral blood and in particular of activated ROShigh
neutrophils, followed by other myeloid cells, such as monocytes
later on.
Lactate production by neutrophils requires NOX/ROS signal-
ing. The NOX/ROS axis in inflamed and activated neutrophils
plays a key role in phagocytic defense against microbial patho-
gens. NOX also triggers ROS-mediated HIF-1α expression in
macrophages17 and activates HIF-1α in prostate cancer27. Thus,
we investigated whether the NOX/ROS axis is also involved in
LPS-induced metabolic activation of BM neutrophils by treating
gp91phox−/− (NOX2 mutated) mice with LPS. We found a
reduction in the levels of BM HIF-1α+ neutrophils compared to
their WT counterparts (Fig. 3a). Interestingly, NOX/ROS defi-
ciency in gp91phox−/− mice impaired the molecular machinery
imperative for lactate production and release by inflammatory
BM neutrophils (indicated by the expression of LDHA and
MCT4, and by BM lactate levels in vivo and in vitro) (Fig. 3b–e,
respectively). These results suggest that the NOX/ROS axis is
essential for HIF-1α activity and lactate production by BM neu-
trophils during acute LPS-induced inflammation.
To determine whether NOX expression in neutrophils or in
BM stromal cells is essential for lactate production, we established
chimeric mice in which hematopoietic cells from the BM of WT
mice were transplanted into gp91phox−/− mice and vice versa
(Supplementary Fig. 4a). As expected, we found that following
LPS administration the NOX/ROS signaling in neutrophils and
not in the stromal compartment is responsible for HIF-1α
elevation (Supplementary Fig. 4b) as well as lactate production
and release (Supplementary Fig. 4c, d). In line with these findings,
we found that the NOX mutation impairs PB neutrophil
activation predominantly in chimeric mice with NOX mutated
in the hematopoietic compartment (Supplementary Fig. 4e).
Consequently, LPS treatment failed to mobilize neutrophils in
general and activated ROShigh neutrophils in particular to the
blood in gp91phox−/− mice compared to their WT counterparts
(Fig. 3f, g). Importantly, lactate injection to bypass endogenous
production and release of lactate by neutrophils, increased the
levels of PB ROShigh neutrophils in gp91phox−/− mice following
LPS treatment (Fig. 3h). Taken together, our data reveal that
NOX/ROS activities are upstream of lactate production in BM
neutrophils since abnormal low metabolic rates were found in
gp91phox−/− neutrophils during the onset of the acute
inflammation.
Table 1 Effects of lactate or LPS treatments on blood pH and glucose levels in WT mice.
Mouse number Gender/age Treatment Blood pH Blood glucose (mg/dL)
#1 Male/8 weeks PBS 6.739 337
#2 Male/8 weeks PBS 6.753 300
#3 Male/8.5 weeks PBS 6.778 249
#4 Male/8.5 weeks PBS 6.829 251
Mean-PBS NA PBS 6.774 284.25
#4 Male/8 weeks Lactate 6.854 225
#5 Male/8 weeks Lactate 6.814 211
#6 Male/8 weeks Lactate 6.863 177
#7 Male/8 weeks Lactate 6.912 192
Mean-lactate NA Lactate 6.860n.s. 201.25*
#8 Male/8 weeks LPS 6.962 131
#9 Male/8 weeks LPS 6.976 127
#10 Male/8.5 weeks LPS 6.743 183
#11 Male/8.5 weeks LPS 6.767 172
Mean-LPS NA LPS 6.862 n.s. 153.25***
Blood pH: n.s. for PBS compared with lactate or LPS. Blood glucose: *p(0.0126) for PBS compared with lactate. ***p(0.0007) for PBS compared with LPS. One-way ANOVA with Tukey’s post hoc test.
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HIF-1α mediates lactate release and neutrophil mobilization.
Activation of HIF-1α is essential for myeloid cell activation, infil-
tration to inflamed tissues and for the regulation of the glycolytic
capacity in these cells28,29. HIF-1α regulates macrophage meta-
bolism by enhancing the expression of glycolytic enzymes30–32.
However, the involvement of HIF-1α in neutrophil-derived
lactate production and release during the early phase of acute
LPS-triggered inflammation has not been demonstrated.
To better understand the function of HIF-1α in lactate
production by activated BM neutrophils, we generated mice with
a myeloid-selective HIF-1α deficiency (deletion of exon 2 that
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compared the expression of LDHA in BM neutrophils of WT,
HIF-1α−/+ (heterozygous) and HIF-1α−/− (homozygous) mice
treated with LPS. Our results demonstrate that HIF-1α−/−
neutrophils displayed lower expression of the glycolytic enzymes
(HK1 and PFKL) compared to WT neutrophils following LPS
treatment (Fig. 4a), suggesting that HIF-1α regulates the
expression of rate limiting glycolytic enzymes during
inflammation.
In addition, we also found a significant increased LDHA
expression following LPS treatment in WT but not in HIF-1α−/+
or HIF-1α−/− mice (Supplementary Fig. 5b, Fig. 4b, respectively).
Another HIF-1α target is the lactate transporter MCT433. In our
myeloid-specific HIF-1α−/+ or HIF-1α−/− mice, LPS treatment
up-regulated within 4 h MCT4 expression on BM neutrophils in a
HIF-1α dependent manner (Supplementary Fig. 5c and Fig. 4c).
Moreover, BM HIF-1α mutated neutrophils failed to release
lactate (Supplementary Fig. 5d, Fig. 4d, e) in contrast to WT BM
neutrophils. Taken together, these results reveal that optimal
neutrophil HIF-1α activity is essential for both high glycolysis
activity and lactate production and release by activated BM
neutrophils during the onset of acute LPS-triggered
inflammation.
Next, we determined the role of HIF-1α in LPS-induced
neutrophil mobilization to the circulation. We found lower levels
of neutrophils in both the PB and in the liver of HIF-1α mutated
mice treated with LPS (Supplementary Fig. 5e, f, Fig. 4f, g) in
comparison with their WT counterparts. Notably, lactate
injection to HIF-1α mutated mice increased neutrophil levels in
both PB and liver, similar to WT mice (Supplementary Fig. 5g, h,
Fig. 4h, i), thus placing HIF-1α upstream of lactate production.
Altogether, these findings indicate that HIF-1α directs meta-
bolic programs in BM neutrophils, including glycolysis as well as
lactate production and release, that are critical for neutrophil
mobilization from the BM during the onset of acute inflamma-
tion. Moreover, our results show that disruption of one HIF-1α
allele is sufficient to impair lactate production and release by
activated BM neutrophils and to reduce their mobilization to the
circulation.
Lactate increases BM endothelium permeability via GPR81.
Others and we have shown that BM sinusoidal vessels are more
permeable and serve as the exclusive trafficking site for both
immature hematopoietic stem cells and mature leukocytes24,34–36.
To assess the involvement of BM sinusoidal “leakiness” in LPS- and
lactate-induced neutrophil mobilization, we measured the pene-
tration of Evans Blue Dye (EBD) from the circulation into the BM,
a classical readout of BM vascular permeability. Indeed, lactate
administration to WT mice increased BM vascular permeability
within 4 h (Fig. 5a). Surprisingly, we identified that both sinusoidal
(sBMECs; Endomucin+ 37,38, CD45−/CD31+/Sca-1− 24,38) and
arterial BM endothelial cells (aBMECs; Endomucin− 37,38, CD45−/
CD31+/Sca-1+ 24) express the lactate-receptor GPR81 (Fig. 5b,
Supplementary Fig. 6a–c). To study the contribution of
GPR81 signaling to BM vascular permeability and neutrophil
mobilization, we treated mice with a specific GPR81 agonist (3,5-
DHBA). This agonist reduced BM neutrophil numbers (Supple-
mentary Fig. 6d) and increased their numbers in PB (Fig. 5c,
Supplementary Fig. 6e) and liver (Supplementary Fig. 6f) 4 h after
administration. The GPR81 agonist also directly enhanced BM
vascular permeability, as reflected by EBD penetration to the BM in
WT mice (Fig. 5d). Importantly, using GPR81−/− mice we found
that GPR81 is essential for enhanced BM vascular permeability
induced by lactate or LPS (Fig. 5e). Strikingly, we observed that
selective depletion of neutrophils resulted in a reduction in BM
vascular permeability in mice exposed to LPS (Fig. 5f) which was
rescued by exogenous lactate treatment. These results suggest that
lactate produced and released from BM neutrophils in the course of
LPS-induced inflammation directly elevates BM vascular perme-
ability by binding and signaling through endothelial GPR81.
Previously it was shown that lactate activates GPR81 and
suppresses cAMP production by reducing adenylyl cyclase
activity21. cAMP regulates endothelial permeability through its
direct binding to Exchange protein directly activated by cAMP
(Epac)39,40, which is critical for the maintenance of vascular
endothelial cadherin (VE–cadherin)-mediated adherence
junctions41,42. Consistent with a role of lactate/GPR81 axis in
enhanced vascular permeability, we found that lactate, LPS or
GPR81 agonist preferentially reduced VE–cadherin expression by
the more permeable sBMECs in WT mice compared to their
GPR81−/− counterparts (Fig. 5g, Supplementary Fig. 6g). Inter-
estingly, this reduction was not observed on the less permeable
aBMECs that express higher levels of surface VE–cadherin to
begin with24 (Supplementary Fig. 6h).
Notably, enforced disruption of VE–cadherin assemblies in
GPR81−/− mice with a VE–cadherin-function blocking antibody
that impairs vascular integrity41, elevated PB neutrophil levels,
similar to WT mice (Fig. 5h). These results further suggest that
VE–cadherin expression and activity in the BM vasculature is
modulated by GPR81 signaling triggered by lactate.
To determine if lactate induces the vascular permeability
changes necessary for optimal BM neutrophil mobilization via the
cAMP/Epac1 axis, we co-injected WT mice with lactate alone or
Fig. 2 Lactate induces rapid BM neutrophil mobilization and recruitment. a BM neutrophil frequency (numbers per 106 acquired cells by flow cytometry)
4 h following i.p. lactate treatment in vivo (n= 6, PBS or 50.5 mg lactate; n= 5, 30mg lactate).***p (PBS vs. 30mg lactate)= 0.004. b, c Quantitative
analysis and representative flow cytometry density plots for b PB neutrophils and c liver neutrophils frequency (n= 8, PBS or 50.5 mg lactate; n= 6, 30mg
lactate) following lactate injection.***p(PBS vs. 30mg lactate in the PB)= 0.0008; **p(PBS vs. 30mg lactate in the liver)= 0.0023; ***p(30mg lactate vs.
50mg lactate in the liver)= 0.0003. d Neutrophil frequency in PB at different time points following 50.5 mg lactate treatment (n= 5). e Representative
TPLSM 3D images 4 h post PBS (left panel) or lactate (right panel) treatment, in calvarial bone of chimeric mice reconstituted with Ly6G tdTomato
neutrophils (red). Sca-1 eGFP marked the endothelial cells (green) and second harmonic generation marked the bone (SHG; blue). White dashed lines
indicate superior sagittal sinus (calvaria central sinus), arrows indicate BM, circulating or mobilized neutrophils. Representative images out of three
independent experiments are shown. Scale bar, 50 μm. f Quantitative analysis for PB ROShigh neutrophils frequency following lactate administration (n=
6). g A schematic illustration of the protocol for LPS with LDHA or MCT4 inhibitors administration. h Frequency of PB neutrophils following LDHA
inhibitors (n= 4, PBS+ vehicle; n= 3, LPS+ vehicle; n= 4, LPS with FX11; n= 5, two injections of PBS or LPS+ PBS; n= 4, LPS with sodium oxamate).
i Frequency of PB ROShigh neutrophils following LDHA inhibitors (n= 3, PBS+ vehicle or LPS+ vehicle; n= 5, LPS with FX11; or two injections of PBS; n= 4,
LPS+ PBS or LPS with sodium oxamate). j, k Frequency of j PB neutrophils or k PB ROShigh neutrophils following MCT4 inhibitor (n= 4). j **p(PBS+
vehicle vs. LPS+ vehicle)= 0.0032; *p(LPS+ vehicle vs. LPS+ CHC)= 0.0163; k ***p(PBS+ vehicle vs. LPS+ vehicle)= 0.0006; **p(LPS+ vehicle vs.
LPS+ CHC)= 0.0073. Data are represented as mean ± SEM from 3 to 5 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001, one-
way ANOVA with Tukey’s post hoc test (a–c, h–k), two-way ANOVA with Bonferroni post hoc test (d) or Student’s two-tailed unpaired t test (f). See also
Supplementary Fig. 2.
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in combination with a selective Epac1 agonist40. We found that
Epac1 agonist reduced lactate-induced BM vascular permeability
(Fig. 5i) and neutrophil mobilization to the circulation (Fig. 5j,
Supplementary Fig. 6i). Altogether, our results indicate lactate-
driven activation of GPR81 signaling in sBMEC and suggest a
downstream reduction in cAMP and Epac1 activation. This may
be the mechanism that reduces VE–cadherin expression leading
to increased BM vascular permeability and enhanced neutrophil
mobilization during acute inflammation (Fig. 5k).
GPR81/lactate signaling mediates neutrophil mobilization.
Next, we investigated the impact of lactate/GPR81 signaling on
neutrophil mobilization. Pharmacological inhibition of
GPR81 signaling43 markedly reduced the effect of lactate on
neutrophil mobilization from the BM to the PB and recruitment
to the liver (Supplementary Fig. 7a–c; respectively). Furthermore,
a significant lactate-induced reduction in BM neutrophil levels
was observed in WT but not in GPR81−/− mice (Fig. 6a), coupled
with a large increase in neutrophil numbers in PB and liver of
WT mice and a smaller but significant increase in the numbers of
PB mobilized neutrophils in GPR81−/− mice treated with lactate
(Fig. 6b, Supplementary Fig. 7d). Furthermore, LPS-induced
mobilization of BM neutrophils was also lower in GPR81−/−
mice compared to their WT counterparts (Fig. 6c, d, Supple-
mentary Fig. 7e). Importantly, this attenuated neutrophil mobi-
lization following LPS treatment in GPR81−/− mice was rescued
by administration of blocking VE–cadherin antibodies41 (Fig. 6e).
This finding implicates LPS as a potent regulator of VE–cadherin
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Fig. 3 Lactate production by neutrophils requires NOX/ROS signaling. a Percentage of BM HIF-1α+ neutrophils in WT (n= 9) and gp91phox−/− (n= 7)
mice treated with either PBS or LPS. **p(WT+ LPS vs. gp91phox−/−+LPS)=0.0012. b Quantitative analysis and representative histogram plot showing LDHA
expression in BM neutrophils from WT (n= 5) and gp91phox−/− (n= 4) mice. **p(WT+ PBS vs. WT+ LPS)=0.0054; *p(WT+ LPS vs. gp91phox−/−
+LPS)= 0.0131. c Quantitative analysis of MCT4 expression on BM neutrophils fromWT (n= 7) and gp91phox−/− (n= 7) mice treated with either PBS or
LPS. *p(gp91phox−/−+PBS vs. gp91phox−/−+LPS)= 0.0424. d BM lactate levels in WT (n= 4, PBS; n= 5, LPS) and gp91phox−/− (n= 5, PBS; n= 6, LPS)
mice treated with LPS. e BM lactate levels released from WT or gp91phox−/− isolated neutrophils treated ex vivo with PBS or LPS (120 ng/ml; n= 4, WT;
n= 3, gp91phox−/−). f, g Frequency of PB neutrophils from WT and gp91phox−/− (f, n= 6; **p(WT+ PBS vs. WT+ LPS)= 0.0058) and ROShigh
neutrophils (g, n= 7, WT+ PBS; n= 6, WT+ LPS; n= 6, gp91phox−/− mice) following LPS injection. h Quantitative analysis and representative histogram
plot of PB ROShigh neutrophils of gp91phox−/− mice treated with PBS, LPS, or LPS together with 50.5 mg lactate (n= 8, PBS or LPS; n= 6, LPS+ lactate).
**p(LPS vs. LPS+ lactate)= 0.0018. Data are represented as mean ± SEM from 3 to 4 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001, one-way ANOVA with Tukey’s post hoc test (h) or two-way ANOVA with Tukey’s post hoc test (a–g). See also Supplementary Fig. 4.
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To determine the relative contributions of vascular, stromal
and hematopoietic GPR81 signaling (Supplementary Fig. 1f,
Supplementary Fig. 3d44–46) to vascular permeability and
neutrophil mobilization induced by lactate we generated chimeric
mice in which hematopoietic cells from the BM of WT mice were
transplanted into GPR81−/− mice and vice versa (Supplementary
Fig. 7f). The effects of lactate treatment to these chimeric mice
demonstrated that lactate/GPR81 signaling in BM endothelial and
stromal cells, but not in hematopoietic cells, control the increase
in BM vascular permeability and neutrophil mobilization
(Fig. 6f–h). Moreover, to better reveal the specific function of
endothelial lactate/GPR81 signaling in neutrophil mobilization,
we generated inducible endothelial-specific GPR81 KO mice. We
observed a significant lactate-induced reduction in BM neutrophil
levels in GPR81flox/flox/Cdh5cre neg (WT counterparts) but not in
endothelial-specific GPR81 KO mice (GPR81flox/flox/Cdh5cre pos;
Fig. 6i), coupled with a large increase in PB neutrophil levels of
WT counterparts and a smaller but significant increase in PB
mobilized neutrophils in endothelial-specific GPR81 KO mice
treated with lactate (Fig. 6j).
The residual lactate-induced neutrophil mobilization we




































WT HIF-1α–/– WT HIF-1α–/– WT HIF-1α–/–





































































































































































































































Fig. 4 HIF-1α mediates lactate release and inflammatory neutrophil mobilization. a Gene expression of glycolytic enzymes in sorted BM neutrophils
following LPS treatment (WT; n= 3, PBS; n= 5, LPS; HIF-1α−/−, n= 3). On each box, the bottom, middle and the top edges indicate the 25th, 50th, and
75th percentiles, respectively. The whiskers extend to the most extreme data points. b Quantitative analysis and representative flow cytometry histogram
plot of LDHA expression in BM neutrophils in WT (n= 6, PBS; n= 7, LPS) vs. HIF-1α−/− (n= 6, PBS; n= 9, LPS) mice. c Quantitative analysis of MCT4
expression on BM neutrophils following either PBS or LPS treatment in WT (n= 6) vs. HIF-1α−/− (n= 7, PBS; n= 6, LPS) mice.***p(WT+ PBS vs. WT+
LPS)= 0.0001; **p(WT+ LPS vs. HIF-1α−/−+LPS)= 0.0053. d BM lactate levels in WT (n= 5) vs. HIF-1α−/− (n= 6) mice. **p(WT+ PBS vs. WT+ LPS)
= 0.0023; **p(WT+ LPS vs. HIF-1α−/−+LPS)= 0.0020. e BM Lactate levels released fromWT or HIF-1α−/− isolated neutrophils treated in vitro with PBS
or LPS (120 ng/ml; n= 4 each group) **p(WT+ PBS vs. WT+ LPS)= 0.0027. f PB neutrophils frequency in WT (n= 7) and HIF-1α−/− (n= 7, PBS; n= 8,
LPS) mice. g Liver neutrophil frequency in WT (n= 8) and HIF-1α−/− (n= 8) mice following LPS treatment. h PB neutrophil frequency in WT (n= 5, PBS; n
= 6, lactate) and HIF-1α−/− (n= 5) mice following 50.5mg lactate treatment. i Liver neutrophil frequency in WT vs. HIF-1α−/− (n= 4, PBS; n= 3, lactate)
following lactate administration. Data are represented as mean ± SEM from 3 to 4 independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001; ****p <
0.0001, two-way ANOVA with Bonferroni post hoc test (a) or two-way ANOVA with Tukey’s post hoc test (b–i). See also Supplementary Fig. 5.
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specific GPR81 KO mice (Fig. 6b, j) raised the possibility that
lactate triggers additional pathways independent of
GPR81 signaling which promote neutrophil mobilization from
the BM. Since the chemokines CXCL1 and CXCL247–51 and the
neutrophil-mobilizing cytokine G-CSF51–53 contribute to the
early stages of neutrophil mobilization and recruitment during
acute inflammation, we next examined the potential effects of
lactate concerning the release of these factors in BM and blood.
Notably, we found that lactate treatment dramatically increased
CXCL1 levels in both compartments in an endothelial-GPR81-
independent manner (Supplementary Fig. 7g, h, Fig. 6k, l). We
also observed a more moderate increase in the levels of CXCL2 in
both BM and blood of WT mice treated with lactate
(Supplementary Fig. 7i, j). Lactate-induced elevation of CXCL1
and CXCL2 most probably downregulated surface expression of
their receptor CXCR2 by PB neutrophils (Supplementary Fig. 7k).
Importantly, we also found that lactate administration dramati-
cally increased blood G-CSF levels in WT mice and a smaller but
a
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significant increase in GPR81−/− (Fig. 6m). These results could
explain the residual lactate-induced neutrophil mobilization we
observed in the two models of GPR81−/− mice and why only
neutrophils are rapidly mobilized 4 h post lactate administration
despite the increased BM vascular permeability. Collectively our
results reveal that the lactate/GPR81 axis is a key regulator of BM
vascular permeability required for optimal mobilization of BM
neutrophils to the blood and their recruitment to inflamed
organs. In addition to this axis, lactate also triggers the release of
neutrophil mobilizing chemokines and G-CSF, key inducers of
rapid neutrophil mobilization from the BM.
Salmonella increases lactate production by BM neutrophils.
Finally, to examine the clinical relevance of our findings, we infected
mice with gram-negative SalmonellaTyphimurium and found
higher levels of lactate in both BM and blood of WT mice (Fig. 7a,
b; respectively), similar to those prompted by LPS (Fig. 1f, Sup-
plementary Fig. 1j). Next, we infected gp91phox−/− mice and
compared their metabolic parameters with WT mice. Our findings
indicate that following the onset of infection (4 h after bacterial
challenge) WT BM neutrophils displayed high generation of ROS,
elevated levels of HIF-1α+ neutrophils as well as lactate production
and release (Fig. 7c–f; respectively). In contrast, similar infection of
gp91phox−/− mice did not increase the numbers of BM HIF-1α+
neutrophils as observed in WT counterparts (Fig. 7d). Interestingly,
the deficiency in NOX/ROS activities in infected gp91phox−/− mice
resulted in impaired rates of lactate production and release from
BM neutrophils infected with Salmonella (Fig. 7e, f). Consequently,
WT mice infected with Salmonella also have higher levels of acti-
vated neutrophils in the blood and liver, as compared to
gp91phox−/− or GPR81−/− mice counterparts (Fig. 7g–i). Of note,
although to a lower extent than in WT mice, elevated levels of liver
neutrophils were also observed in Salmonella-infected gp91phox−/−
or GPR81−/− mice, suggesting that the NOX and GPR81 axes are
major but not exclusive players in Salmonella-induced neutrophil
recruitment.
Altogether, our data reveals that the regulatory mechanisms
identified in the present work by which neutrophils respond to
enforced LPS challenges are also activated during physiological
bacterial infections with Salmonella, demonstrating its clinical
relevance.
Discussion
In this study, we describe a role for the metabolite lactate
implicated in the early phase of acute inflammation triggered by
bacterial LPS. Our findings reveal that lactate acts as a critical
regulator of rapid neutrophil mobilization from the BM to the
circulation induced by LPS. We also found that LPS-induced
inflammation enhances glycolytic activities in BM neutrophils
that promote lactate production and release. Lactate released
from inflammatory BM neutrophils triggers their mobilization
acting on its receptor GPR81 functionally expressed by endo-
thelial cells to locally increase vascular permeability. In addition,
lactate facilitates rapid neutrophil mobilization from the BM also
by elevating the levels of neutrophil-attracting chemokines
CXCL1 and CXCL2, and by increasing the release of the cytokine
G-CSF. A schematic model summarizing these processes is pre-
sented in Fig. 8.
Lactate is not only a waste byproduct of cell metabolism that
merely accumulates at inflammatory sites54 and at the tumor
microenvironment, but instead is an effector molecule that con-
tributes to inflammation and to both, onset and progression of
cancer55. Recently, lactate was also identified as an effector
metabolite that triggers multiple cell signaling pathways in var-
ious organs21,22,56,57. Furthermore, the role of lactate in regula-
tion of immune cells is documented in different diseases,
including cancer and multiple sclerosis55,58–60. Hence, inhibitors
to lactate dehydrogenase and MCTs could be effective targets to
attenuate undesirable neutrophil mobilization in pathological
inflammatory processes and potentially also in malignancies
facilitated by tumor helper neutrophils61. Since lactate can also
boost TLR4 activation and transcription of pro-inflammatory
genes through NF-κB signaling in innate immune cells like
macrophages18, such inhibitors may be useful in controlling
pathologies resulting in excess activation of these subsets.
Importantly, elevated lactate levels coinciding with the rise of
neutrophils in the circulation and inflamed tissues are associated
with pathological conditions including shock, sepsis, and ische-
mia62. Lactate was also found to be released by human neu-
trophils12 and it was shown that glucose uptake, enhanced
glycolysis and lactate promoted neutrophil functions like pha-
gocytic activity63 and neutrophil extracellular traps
formation64,65. However, how neutrophils produce lactate, and
how this metabolite affects neutrophil function and mobilization
during acute inflammation have been open questions. Our results
directly link lactate production by BM neutrophils to ROS gen-
eration by the phagocytic NOX machinery and activation of HIF-
1α. Indeed, defects in this inflammatory metabolic pathway were
found in neutrophils derived from NOX−/− (gp91phox−/−)
mice treated with LPS or infected with Salmonella. In addition,
NOX−/− mice treated with LPS mobilized reduced levels of
neutrophils in general and activated ROShigh neutrophils in
particular. Importantly, lactate treatment preferentially restored
Fig. 5 Lactate downregulates VE–cadherin and increases vascular permeability. a Levels of BM Evans Blue Dye (EBD) absorbance per femur at 620 nm in
WT mice treated with PBS or lactate (n= 5). b Representative fluorescence images of Endomucin (green), GPR81 (red; RFP), and nuclei (blue; DAPI) in the
femoral diaphysis of GRP81-RFP reporter mice; yellow indicates Endomucin+ GPR81+ sinusoidal BM endothelial cells. Representative images out of four
independent experiments are shown. Scale bar indicates 20 μm. c PB neutrophils frequency following 4 h post administration of GPR81 agonist in WT mice
(n= 7, PBS; n= 6, GPR81 agonist). ***p(0.0002). d–f Levels of BM EBD absorbance following GPR81 agonist treatment to WT mice (d, n= 6, PBS; n= 4,
GPR81 agonist; ***p(0.0009)), after lactate or LPS injection to WT vs. GPR81−/− mice (e, n= 5, WT+ PBS or lactate; n= 3, WT+ LPS; n= 3, GPR81−/−
+ PBS; n= 4, GPR81−/−+ lactate; n= 3, GPR81−/−+ LPS) and following neutrophil depletion and exposure to LPS and lactate in WT mice (f, n= 5, PBS;
n= 3, LPS; n= 5, α-Ly6G Abs+ LPS; n= 3, α-Ly6G Abs+ LPS+ lactate). g Quantitative analysis and representative flow cytometry histogram plot of
surface VE–cadherin expression on sBMEC 30min post injection of lactate or LPS to WT vs. GPR81−/− mice (WT; n= 5, PBS or LPS; n= 6, lactate;
GPR81−/−; n= 6, PBS; n= 5, lactate; n= 4, LPS). h Quantitative analysis and representative flow cytometry density plots for PB neutrophils following
administration of blocking anti-VE–cadherin antibodies to WT vs. GPR81−/− mice (n= 4 per group). i, j Levels of BM EBD absorbance and neutrophil
frequency in PB following treatment with lactate alone or with Epac1 agonist (i, n= 4 per group; j, n= 5 per group). i **p(PBS vs. lactate)= 0.0018; ***p
(lactate vs. lactate+Epac1 agonist)= 0.0009; j **p (PBS vs. lactate)= 0.0013; ***p (lactate vs. lactate+Epac1 agonist)= 0.0008. k A scheme depicting
lactate mode of action controlling BM vascular permeability via GPR81 signaling. Data are represented as mean ± SEM from 4 to 5 independent
experiments. **p < 0.01; ***p < 0.001; ****p < 0.0001, Student’s two-tailed unpaired t test (a, c, d), one-way ANOVA with Tukey’s post hoc test (f, i, j) or
two-way ANOVA with Tukey’s post hoc test (e, g, h). See also Supplementary Fig. 6.
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the reduced levels of mobilized ROShigh neutrophils in the blood
of NOX−/− mice exposed to LPS.
Distinct metabolic pathways play pivotal roles in immune cell
regulation and function. In particular, HIF-1α controls key gly-
colytic programs in many cell types and different hypoxic
environments32,33,66. However, LPS can promote glycolysis and
induce HIF-1α expression in macrophages even under non-
hypoxic conditions. We report that LPS increased glucose uptake
and triggered the activities of glycolytic enzymes in BM neu-
trophils via HIF-1α elevation. Indeed, using mice with a myeloid-
specific defect in HIF-1α, we found that this transcription factor
is critical for glycolysis and plays essential roles in lactate pro-
duction and release by BM neutrophils during acute inflamma-
tory responses, key checkpoints in neutrophil mobilization from
the BM. Interestingly, in support of our results, intense exercise
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neutrophil–endothelial cell interactions in the muscle micro-
vasculature in a ROS-dependent manner66. However, in that
study lactate was not confirmed to act as a direct mediator of
neutrophil–endothelial interactions. In addition, a recent study
reported that facilitating the crosstalk of neutrophils with endo-
thelial cells improves blood vessel regeneration, and hemato-
poietic recovery67. Our results demonstrate that during the early
phase of acute inflammation, LPS activates BM neutrophils to
produce and release lactate to the BM microenvironment. Lactate
within the BM communicates with BM-blood endothelial vessels
to open the junctions for neutrophil mobilization and recruitment
through GPR81 signaling, to distant infected organs. LPS can
mobilize neutrophils via direct and indirect mechanisms, there-
fore, we cannot rule out that the effects of LPS challenge may also
involve other BM cell types which functionally express TLR4.
Previously, the neurotransmitter neuropeptide Y (NPY) acti-
vation in endothelial cells (ECs) was found to reduce
VE–cadherin expression along ECs junctions, resulting in
increased vascular permeability and hematopoietic stem and
progenitor cell (HSPC) mobilization42. Along these lines, we
found that mechanistically, lactate signaling via its endothelial
GPR81 receptor decreased VE–cadherin expression preferentially
by the more permeable sinusoidal BM ECs, which enhances BM
vascular permeability and neutrophil mobilization from the BM.
Properties of the endothelial barrier are normally maintained by
high levels of cAMP. This secondary messenger activates Epac1
and its main downstream GTPase, Rap-1 reported to stabilize
VE–cadherin assemblies, which is critical for low vascular per-
meability. Endothelial barrier disruption by inflammatory stimuli
such as bacterial LPS68 or TNF-α69 is partially associated with
decreased cAMP and Epac1 activity as well as reduced
VE–cadherin expression. These mechanisms may act in concert
with the lactate-triggered GPR81 signaling axis found by us to
acquire the threshold endothelial permeability, critical for neu-
trophil mobilization from the BM24,34.
G-CSF is a major neutrophil-mobilizing cytokine under both
basal and stress conditions2,51,70,71. G-CSF is also a hematopoietic
cytokine, produced by different BM cell types, including ECs52,
osteoblasts72, and osteocytes73. In addition, G-CSF has multiple
functions including regulation of neutrophil progenitor cell pro-
liferation and differentiation52 and the functional activation of
neutrophils74. Several other neutrophil-mobilizing agents are
responsible for rapid neutrophil mobilization during the early
stage of acute inflammation, the most notable being CXCR2
ligands (CXCL1 and CXCL251,75). At peripheral sites of inflam-
mation CXCL1 produced by inflamed ECs can also mediate
neutrophil adhesion and intraluminal crawling, whereas CXCL2-
produced by neutrophils is implicated in neutrophil breaching of
endothelial-cells junctions50. In addition to its direct effect on BM
vascular permeability, lactate acts dramatically on BM neutrophil
rapid mobilization by elevating the levels of circulating G-CSF
and the chemokines CXCL1 and CXCL2, leading to down-
regulation of CXCR2 expression on blood neutrophils. A recent
study76 reported that G-CSF produced in response to Escherichia
coli-challenge, inhibits CXCR2-mediated cellular signaling. The
reduction in CXCR2 expression we observed in our model fol-
lowing lactate treatment can therefore, stem from both inter-
nalization induced by CXCL1/2 upregulation as well as from G-
CSF induced inhibition. Importantly, lactate elevated CXCL1
levels independently of GPR81 signaling and increased G-CSF in
both GPR81-dependent and -independent manners. These results
may explain the residual lactate-induced neutrophil mobilization
we observed in GPR81−/− mice and why only neutrophils are
rapidly mobilized 4 h following lactate treatment despite the
increased BM vascular permeability. In light of our results, we
hypothesize that lactate induces the release of CXCL1, CXCL2,
and G-CSF preferentially via its influx transporter MCT1. In
support of our results, a recent study showed that in addition to
chemokines release, increased lung vascular permeability can also
impact neutrophil trafficking77. Our model indicates that lactate
acts as a pro-inflammatory factor that enhances neutrophil
mobilization via increasing BM vascular permeability and ele-
vating chemokines/G-CSF that are pivotal features of an acute
inflammatory response.
In addition to lactate, neutrophils release additional effector
molecules such as proteolytic enzymes to facilitate their breaching
of endothelial junctions78,79. Our study is, however, the first
example of a neutrophil-released metabolite, which is a potential
target for modulating neutrophil mobilization to peripheral
organs exposed to acute infections. Our findings should also
prompt an exploration for additional metabolites potentially
released by other leukocyte subsets with homologous ability to
modulate their barrier crossing under various inflammatory
stresses.
Methods
Mice. C57BL/6 mice were purchased from Harlan Laboratories (Rehovot, Israel).
loxP-flanked HIF-1α (B6.129- Hif1atm3Rsjo/J) mice, LysM-Cre (B6.129P2-
Lyz2tm1(cre)Ifo/J) mice, gp91phox−/− (B6.129S-Cybbtm1Din/J) mice and trans-
genic Ly6a(Sca-1)-eGFP mice were purchased from Jackson Laboratories. Trans-
genic LysM-GFP mice were kindly provided by G. Shachar (Weizmann Institute,
Israel). GPR81−/− and GPR81-RFP mice were kindly provided by S. Offermanns
(Department of Pharmacology, Max-Planck-Institute for Heart and Lung Research,
Germany). Catchup (Ly6G tdTomato) mice were kindly provided by M. Gunzer
(University Duisburg-Essen, Germany). Conditional mutants carrying loxP-
flanked GPR81 were kindly provided by Z. Gerhart-Hines (University of Copen-
hagen, Denmark). To induce endothelial-specific Cre activity and GPR81 inacti-
vation/expression, adult VE–cadherin (Cdh5, PAC)-CreERT2 mice80 were
interbred with GPR81flox/flox (conducted in the lab of S. Offermanns; Max-Planck-
Institute for Heart and Lung Research, Germany). Mice were injected
Fig. 6 GPR81/lactate signaling mediates neutrophil mobilization. a, b Frequency of neutrophils in the BM (a, n= 9) and quantitative analysis and
representative flow cytometry density plots for PB neutrophils (b, n= 8) following lactate treatment in WT vs. GPR81−/− mice. **p(GPR81−/−+ PBS vs.
GPR81−/−+ lactate)=0.0017. c Frequency of BM neutrophils in WT (n= 9, PBS; n= 8, LPS) vs. GPR81−/− (n= 9, PBS; n= 8, LPS) mice following LPS
treatment. d Frequency of PB neutrophils following LPS administration (n= 7). e Quantitative analysis and representative flow cytometry density plots for
PB neutrophils following blocking VE–cadherin antibodies in GPR81−/− mice (n= 4). *p(LPS vs. αVE–Cad+ LPS)= 0.0402. f Levels of BM EBD absorbance
following lactate treatment in chimeric mice (n= 5, WT to WT+ PBS; n= 4, WT to WT+ lactate; n= 4, GPR81−/− to WT; n= 4, WT to GPR81−/−). g, h
Neutrophil frequency in the PB (g, n= 4, WT to WT; n= 3, GPR81−/− to WT; n= 5, WT to GPR81−/−), and in the liver of chimeric mice (h, n= 4, WT to
WT; n= 3, GPR81−/− to WT; n= 5, WT to GPR81−/−) following lactate administration. i, j Frequency of neutrophils in the BM (i; n= 5, PBS; n= 6, lactate)
and blood (j, n= 6) following lactate treatment in GPR81f/f/Cdh5cre neg vs. GPR81f/f/Cdh5cre pos mice. k, l Plasma protein levels of CXCL1 in k WT vs.
GPR81−/− mice (WT; n= 9, PBS; n= 8, lactate; GPR81−/−; n= 8) or l GPR81f/f/Cdh5cre neg vs. GPR81f/f/Cdh5cre pos mice (n= 6, PBS; n= 7, lactate; per
mice group) following lactate treatment. m Plasma protein levels of G-CSF in WT vs. GPR81−/− mice (n= 6, WT+ PBS, WT+ lactate and GPR81−/−+
lactate; n= 5 GPR81−/−+ PBS) following lactate treatment. Data are represented as mean ± SEM from 3 to 5 independent experiments. *p < 0.05; **p <
0.01; ***p < 0.001; ****p < 0.0001, two-way ANOVA with Tukey’s post hoc test (a–d, f–m) or one-way ANOVA with Tukey’s post hoc test (e). See also
Supplementary Fig. 7.
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intraperitoneally (i.p.) with Tamoxifen (Sigma, T5648) at 1 mg per mouse per day
for 5 days. Mice were allowed to recover for 3 weeks after tamoxifen injections,
before experimental analysis. Mice carrying only GPR81flox/flox mutation (Cdh5 cre
negative) were used as WT controls. Primers used to test the presence of the Cdh5-
CreERT2 recombinase gene were: 5′-ACTGGGTCCTGATGGTGCC-3′ and 5′-
GTGAAACAGCATTGCTGTCACTT-3′. To introduce a dysfunctional HIF-1α in
a myeloid-specific lineage, we crossed mice containing loxP sites flanking exon 2 of
HIF1α with LysM-Cre mice. All mouse offspring from all strains were routinely
genotyped using polymerase chain reaction analysis of DNA from tail biopsies.
Primers used (for HIF-1α flox/LysM Cre) to distinguish floxed from non-floxed
alleles were: 5′-GCA GTT AAG AGC ACT AGT TG-3′ and 5′-GGA GCT ATC
TCT CTA GAC C-3′ for HIF-1α81. Primers used to test the presence or absence of
the LyzM Cre recombinase gene were: 5′CRE (TGCAAGTTGAATAACCGGAAA)
and 3′CRE (CTAGAGCCTGTTTTGCACGTTC).
Breeding and all experimental procedures were monitored by the Veterinary
Resources Unit of the Weizmann Institute and were approved by the Institute
Animal Care and Use Committee (IACUC). All mutated or transgenic mouse
strains were compared to strain-matched WT C57BL/6 sex-and age-matched
controls. Totally, 8–10-week-old mice, both male, and female were used for all
experiments. BM cells were obtained by flushing long bones with phosphate-
buffered saline (PBS), and peripheral blood was collected from the heart using
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Fig. 7 Salmonella increases lactate production by inflammatory BM neutrophils. a, b Lactate levels in (a) BM or (b) blood fromWT mice treated with PBS
or Salmonella (n= 5). a ***p(0.0004); b **p(0.0081). c Quantitative analysis of ROS production in BM neutrophils from WT (n= 7) vs. gp91phox−/−
(n= 6) mice infected with Salmonella. d Percentage of BM HIF-1α+ neutrophils in WT (n= 9) vs. gp91phox−/− (n= 9). e Quantitative analysis and
representative flow cytometry histogram plot of LDHA expression in BM neutrophils from WT (n= 7, PBS; n= 6, Salmonella; ***p(0.0001)) vs.
gp91phox−/− (n= 6, PBS; n= 5, Salmonella) mice. f Quantitative analysis of MCT4 expression on BM neutrophils from WT (n= 6; ***p(0.0008)) and
gp91phox−/− (n= 5) mice. g Quantitative analysis and representative flow cytometry histogram plot of ROS production in PB neutrophils from WT (n= 5;
**p(0.0030)) vs. gp91phox−/− (n= 7, PBS; n= 6, Salmonella) mice. h Frequency of PB neutrophils from WT (n= 7, PBS; n= 6, Salmonella) vs.
gp91phox−/− (n= 7) and GPR81−/− (n= 8) mice. i Frequency of liver neutrophils from WT (n= 7, PBS; n= 6, Salmonella) vs. gp91phox−/− (n= 7) and
GPR81−/− (n= 8) mice. Data are represented as mean ± SEM from three independent experiments. *p < 0.05; **p < 0.01; ***p < 0.001, ****p < 0.0001,
Student’s two-tailed unpaired t test (a, b), two-way ANOVA with Tukey’s post hoc test (c–i).
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In vivo treatments. Sodium-Lactate (Sigma) was injected intraperitoneally (i.p.; 30
or 50.5 mg dissolved in 200 μl PBS, pH‐adjusted to ~7.0) 4 h or 30 min before mice
sacrifice and cells harvest. These lactate doses are non-lethal and do not cause
acidosis (Table 1) or severe inflammatory side effects in strains applied for this
study21,55,82. In order to induce acute inflammation, LPS (from Escherichia coli
0111:B4, L2630, Sigma) was injected i.p. (at 50 µg per injection83) 4 h or 30 min
before cells were harvested. This LPS dose is non-lethal and does not cause acidosis
(Table 1) in strains used for this study.
LDHA inhibitors; Sodium oxamate (Sigma, dissolved in PBS, 750 mg/kg) or
FX11 (selective, reversible, NADH competitive LDHA, Calbiochem, dissolved in
DMSO, 42 μg/mouse) and MCT4 inhibitor CHC (2-Cyano-3-(4-hydroxyphenyl)-
2-propenoic acid, TOCRIS, dissolved in DMSO, 40 μM/mouse) were injected i.p.
three times: at 7AM together with LPS, and two additional injections of LDHA
inhibitor or MCT4 inhibitor 15 and 30 min following the first injection, to inhibit
LDHA or MCT4 activity. PBS or PBS with DMSO served as vehicle control. All the
mice received the same number of injections.
We noticed that the number of vehicle injections affects the levels and
phenotype of circulating neutrophils. For example, experiments that included four
injections of the vehicles PBS or PBS with DMSO, like in Fig. 2. These extra
injections dramatically increased the number of total PB neutrophils compared to a
single PBS injection. We observed two clear populations of PB neutrophils
(CD11bint/Ly6Ghigh and CD11bhigh/Ly6Ghigh) following PBS injections but only
the CD11bhigh/Ly6Ghigh population was affected by LPS (increased to 15% and
decreased in the presence of the inhibitors; Fig. 2h–k). The CD11bint/Ly6Ghigh
population, which increased only after PBS injections (without elevation of CD11b
expression, a marker for primed and activated neutrophils following bacterial
signals) disappeared after LPS treatment.
GPR81 antagonist (3-hydroxy-butyrate; 3-OBA, Sigma, dissolved in PBS) was
injected i.p. at 15 mM/mouse three times, at 7 A.M. together with lactate and two
additional injections were performed 15 and 30 min following the first injection, to
inhibit GPR81 signaling. GPR81 agonist (3,5-dihydroxybenzoic acid; 3,5-DHBA,
TOCRIS, dissolved in PBS) was injected i.p. at 30 mg/kg 4 h or 30 min before cells
were harvested. Epac1 agonist (8-CPT-2′-O-Me-cAMP; TOCRIS, dissolved in PBS)
was injected i.p. at 1 mM/mouse twice, at 7 A.M. together with lactate and one
additional injection was performed 1 h following the first injection, to inhibit the
BM vascular permeability.
For quantifying the number of liver neutrophils, a similar piece of the liver






















































Fig. 8 Mechanisms of lactate-induced neutrophil mobilization from the BM. Our model suggests that enhanced lactate-produced by BM neutrophils
during bacterial infection induces neutrophil mobilization by modulating metabolic signaling in BM endothelial cells. LPS binds TLR4 expressed on
neutrophils that directly activates NADPH oxidase (NOX) and enhances glucose uptake via a glucose transporter 1a. Glucose in turn, is converted to
pyruvate by the glycolysis pathway 1b. NOX activity leads to ROS production (2) which elevates HIF-1α expression. HIF-1α in turn, induces downstream
expression of LDHA that converts pyruvate to lactate 3a. HIF-1α also up-regulates the lactate transporter MCT4 3b to allow lactate release (4). Under
steady-state conditions, surface VE–cadherin on endothelial cells (ECs) is highly expressed, which maintains the endothelial barrier integrity with low
permeability (a). During inflammation (b), lactate released from BM neutrophils binds to GPR81 on sinusoidal BM endothelial cells 5a, activates Gi protein
and thereby reduces cAMP/Epac1 activity 5b. Consequently, lactate via GPR81 signaling decreases surface VE–cadherin expression (5c), leading to higher
BM vascular permeability (6). In addition, lactate elevates CXCL1 and G-CSF levels (produced by different cells including ECs50,52) also in a GPR81-
independent manner 7a with more moderate increases in CXCL2 levels in WT mice (most probably produced by BM neutrophils50). Lactate-induced
elevation of CXCL1, CXCL2, and G-CSF downregulates surface CXCR2 expression on PB neutrophils 7b facilitating neutrophil mobilization (8). Taken
together, LPS-induced lactate promotes rapid neutrophil mobilization from the BM to the blood (8) preferentially via BM GPR81/VE–cadherin-dependent
(5–6) and also by GPR81-independent (7) pathways.
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Neutrophil depletion. Totally, 125 μg purified anti-Ly6G antibody67 (clone 1A8,
Bio X Cell) diluted in 200 μl PBS was administered i.p. at 24 h prior to LPS
injection. All the mice were sacrificed at 11 A.M.
Gr-1 and CD11b antibodies were used for BM neutrophils detection. Frequency
of BM FSChigh/SSChigh cells reduction was observed following Ly6G depletion
(Supplementary Fig. 1c). In addition, depletion of ~85% of BM neutrophils (Gr-
1high/CD11bhigh) was also observed following depletion (Supplementary Fig. 1c).
Blood pH measurement. Measurements of blood pH and glucose levels in WT
mice following PBS, lactate or LPS treatment, were performed by using i-STAT
clinical analyzer (Abaxis). Peripheral blood was collected from the heart using
syringes coated with lithium heparin. For the i-STAT analysis 100 μl of blood was
immediately placed into a cartridge (i-STAT CG8, PET-VETBIOMED) to deter-
mine the parameters following the manufacturer’s instructions. The i-STAT
machine was calibrated using the Electronic Simulation module before the analysis
of samples. Blood glucose levels were used as a control for the quality, and relia-
bility of the machine (test). Both lactate and LPS treatments reduced the blood
levels of metabolic glucose without affecting the blood pH (Table 1).
Endothelial VE–cadherin disruption. Purified blocking anti-VE–cadherin anti-
bodies (50 or 100 μg as indicated, clone BV13, functional Grade, Invitrogen) was
administered intravenously (i.v.) to WT or GPR81−/− mice 4 h before cells harvest
in order to disrupt VE–cadherin homotypic adhesion, clustering and endothelial
integrity.
For rescue experiments (Fig. 6e) 50 μg of purified anti-VE–cadherin antibodies
were administered 1 h (at 6:00 A.M.) before LPS injection (at 7:00 A.M.). All the
mice were sacrificed at 11:00 A.M. PBS alone served as a vehicle control.
Neutrophil isolation. Flushed BM cells (from WT and mutated mice) were
resuspended in 200 μl MACS buffer (2 mM EDTA, 0.5% bovine serum albumin in
PBS) and BM neutrophils were isolated according to the protocol of “Neutrophil
isolation kit, mouse” by Miltenyi. The yields were approximately 8 × 106 cells in
total (for 6 bones of two legs), and the purity was >94%.
In vitro treatment for lactate production. BM isolated neutrophils (1 × 106) were
seeded on 24-well plate in serum-free RPMI-1640 culture media and then stimu-
lated with either PBS or 120 ng/ml LPS for 5 h. Cell-free supernatants from non-
stimulated or LPS-stimulated cultured neutrophils were harvested at 5 h and
analyzed for lactate content using an L-lactate assay (700510, Cayman).
Flow cytometry. Cell populations were analyzed with MACSQuant (models 10
and VYB, Miltenyi, Bergisch Gladbach Germany), data were analyzed with
MACSQant software. Cellular expression levels were analyzed and presented as
MFI (mean fluorescent intensity). Isolated peripheral blood and liver cells under-
went red blood cell lysis (R7577, Sigma) before staining. Flushed BM, peripheral
blood and liver cells were stained for 30 min at 4 °C in flow cytometry buffer (PBS,
10% fetal bovine serum and 0.02% azide). For intracellular antigens staining (HIF-
1α and LDHA), cell surface staining was followed by cell fixation and permeabi-
lization with the Cytofix/Cytoperm kit (BD Biosciences) according to the manu-
facturer’s instructions. For neutrophil staining, we used anti-Ly6G-APC (A18,
Biogems) and anti-CD11b-FITC (M1/70, BioLegend). For detection of depleted
neutrophils, we used GR-1-APC (RB6-8C5, BioLegend). For sorting neutrophils,
we used a combination of CD45-PE (30-F11, 103106)/Ly6G-APC/CD11b-FITC (all
from BioLegend). For monocytes/macrophages staining, we used anti-Ly6C-PE-
Cy7 and anti-CD11b-FITC (BioLegend). For lymphocytes staining, we used anti-
CD4-FITC (GK15, 103106) and anti-B220-PE (RA3-6B2, 103208) (all from Bio-
Legend). For intracellular ROS detection, cells were incubated for 10 min at 37 °C
with 2 μM hydroethidine (Life Technologies) prior to cell surface staining for
neutrophil markers as described above. For glucose uptake detection, cells were
incubated for 30 min at 37 °C with the glucose analog 2-NBDG (Life Technologies).
Staining without the addition of the ROS or 2-NBDG probe was considered the
baseline for gating the positive population. For MCT4 expression, we used rabbit
anti-mouse MCT4 (H-90, Santa Cruz) followed by anti-rabbit PE (catalog number:
711-116-152, Jackson ImmunoResearch). Data presenting MCT4 staining were
obtained using two different flow cytometer analyzers, with different settings.
Quantitative analyses presented in Figs. 1i, 3c, and Supplementary Fig. 5c were
obtained using MACSQuant analyzer10, while Fig. 4c and Supplementary Fig. 4d
were obtained using MACSQuant VYB. For MCT1 expression, we stained with
rabbit anti-mouse MCT1 (M-45, Santa Cruz, sc-50325, B2316) followed by anti-
rabbit PE (Jackson ImmunoResearch). HIF-1α was identified using conjugated
anti-h/m HIF-1α-PE (241812, R&D). For LDHA expression, we stained with rabbit
anti-mouse LDHA (EPR1564, Abcam) followed by anti-rabbit PE (Jackson
ImmunoResearch). Data presenting LDHA staining were obtained using two dif-
ferent flow cytometer analyzers, with different settings. Quantitative analyses
presented in Figs. 1e, 3b, and Supplementary Fig. 5b were obtained using
MACSQuant analyzer10, while Figs. 4b, 7e, and Supplementary Fig. 4c were
obtained using MACSQuant VYB. For BM endothelial cell staining, BM cells were
flushed with Liver digest medium (LDM; Invitrogen) supplemented with 0.01%
DNase 1 (Roche) and mechanically crushed by mortar and pestle in the same
medium, followed by 30 min digestion at 37 °C with shaking. Following incubation
time, cells were washed twice with PBS. Next, cells underwent red blood cell lysis
(R7577, Sigma), filtered and washed extensively before staining. Sinusoidal or
arterials endothelial cells were identified by staining with anti-CD45-APC, anti-
CD31-PE-Cy7, and anti-Sca-1-PE or Pacific Blue (all from BioLegend) as descri-
bed24. For GPR81 expression, we stained with rabbit anti-mouse GPR81 (Novus,
catalog number NLS2095) followed by anti-rabbit PE (Jackson ImmunoResearch).
For VE–cadherin expression, we stained with anti-VE–cadherin-BV421 conjugated
antibody (11D4.1, BD Bioscience).
For FACS staining, we used the fluorescence minus one (FMO) as a negative
control, which contains all the fluorochromes except for the one that is being
measured. The FMO in the manuscript is presented as “secondary only”.
BM cell sorting. BM single-cell suspensions were sorted gating on CD45+/
CD11b+/Ly6Ghigh cells using SORP-FACSAriaII machine with a 100 μm nozzle.
Dead cells were excluded based on DAPI incorporation reaching purities greater
than 94%.
Cells (9000–35,000 cells per sample) were sorted into Eppendorf tubes
containing 100 μl lysis buffer (RLT buffer (QIAGEN, 79216) with 1% 2-
Mercaptoethanol). After sorting, lysis buffer was added to the samples to reach 2–4
times of the volume of the sorted cells. Cell lysis was achieved by vortex for 30 s.
Samples were snap-frozen on dry ice and stored at −80 °C until processed.
Bulk-seq library preparation. Samples were defrosted and washed with AMPure
XP bead (BECKMAN COULTER, A63881) at 1:1 ratio. RNA libraries from the
bulk tissues were prepared using mcSCRBseq protocol84 with minor modifications.
RT reaction was applied directly on the beads with a final volume of 20 µl. RNase
free water (8.4 μl) was added to the beads and mixed with 9.6 μl reaction buffer (1×
Maxima H Buffer, 1 mM dNTPs, 2 μM TSO* E5V6NEXT, 7.5% PEG8000, 20U
Maxima H enzyme, 1 μl barcoded RT primer). Subsequent steps were applied as
mentioned in the protocol. Library final concentration of 2.4 pM was loaded on
NextSeq 550 (Illumina) sequencing machine aiming for 20M reads per sample.
Raw files were converted to FASTQ files using bcl2fastq 2.17 (Illumina), to obtain
the UMI counts, fastq reads were aligned to the mouse reference genome
GRCm38.94 (Ensembl) using zUMI package85 with the following parameters: RD1
16 bp, RD2 66 bp with a barcode (i7) length of 8 bp. UMI counts for “coding_-
genes” were processed with the edgeR package running on R 3.5.1. Samples with
less than 10k UMI counts were removed. Genes that were expressed in cpm >10
and in two or more samples were retained for the downstream analysis.
Data processing. The final cpm (counts per million) table included 14 mice (n=
8, WT: (n= 3, PBS; n= 5, LPS); n= 6, HIF-1α−/− (n= 3 per group)). We nor-
malized the cpm values by the sum of all genes for each sample. We next divided
the gene expression values in each sample by the sum for all genes that individually
make up less than 1% of the sample’s summed expression values. For each analyzed
group, we computed the means and standard errors of the means over the different
mice. Only genes with mean values higher than 5 × 10−6 were considered.
Bacterial preparation. Salmonella typhimurium (strain SL1344) were kindly
provided by Roi Avraham (Weizmann Institute, Israel). Salmonella working con-
centration of 2 × 108 cell/ml was prepared from an overnight inoculum in LB
(Lysogeny broth) incubated at 37 °C with shaking. The bacteria were washed and
diluted with PBS to the desired concentration in 200 µl and was administered i.p. at
7 A.M. All the mice were sacrificed at 11 A.M. PBS alone served as vehicle control.
This Salmonella dose is nonlethal in strains applied for this study.
L-Lactate measurement. The L-lactate assay was performed by using the L-lactate
kit (700510, Cayman) which provides a fluorescence method according to the
manufacturer’s instructions.
For detecting BM L-lactate, six bones from each mouse were flushed with 1 ml
PBS and BM extracellular fluid samples (supernatants) were prepared according to
the manufacturer’s instructions. BM supernatants of WT, NOX mutated
(gp91phox−/−), and HIF-1α mutated (heterozygous and homozygous) mice were
collected 4 h post LPS, and BM supernatants of WT mice collected 4 h post lactate
or Salmonella treatments. For detecting blood L-lactate, plasma was collected from
WT mice following LPS, lactate or Salmonella treatments and prepared according
to the manufacturer’s instructions. The levels of BM lactate of WT mice treated
with PBS varied between independent experiments (Figs. 1f, 7a, and Supplementary
Fig. 2a), since new L-lactate kits were used in each experiment. However, the trend
following LPS or Salmonella treatment was similar in all the experiments.
In this assay, lactate dehydrogenase catalyzes the oxidation of lactate to
pyruvate, along with the concomitant reduction of NAD+ to NADH. NADH reacts
with the fluorescence substrate to yield a highly fluorescent product, which is
analyzed with an excitation wavelength of 530–540 nm and an emission
wavelength of 585–595 nm.
Imaging flow cytometry analysis. BM cells were prepared as indicated for flow
cytometry, stained for extracellular markers (MCT1, MCT1, and GPR81) and
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analyzed using an ImageStreamX (Amnis corp., part of EMD-Millipore, Seattle,
WA) machine. Samples were visualized and analyzed for the expression of markers
with IDEAS 6.2 software (Amnis). Single stained control cells were used to com-
pensate fluorescence between channel images to avoid emission spectra overlap.
Cells were gated for single cells with the area and aspect ratio features and for
focused cells, using the Gradient RMS feature. Cells were then gated for the
selection of positively stained cells based on their pixel intensity, as set by the cutoff
with secondary antibody control staining. Three samples from three mice were
analyzed to confirm biological repeats of observed data.
Establishment of chimeric mice. Recipient GPR81−/−, gp91phox−/−, Sca-1 eGFP
or WT mice were subjected to irradiation (950 cGY) 16–20 h before transplanta-
tion. Irradiated mice received 8–10 million donor total BM cells (filtered and
resuspended in RPMI−/−) and the cells were allowed to repopulate for 4 weeks
before conducting experiments. Four weeks after transplantation, recipient
(transplanted) mice were treated with lactate or LPS and sacrificed 4 h later at 11 A.
M. to determine BM vascular permeability, neutrophil mobilization and metabolic
changes in BM neutrophils. For neutrophil imaging, recipient Sca-1 eGFP mice
were irradiated (as mentioned above) and received 8-10 million donor total BM
cells (Catchup; Ly6G tdTomato). Four weeks after transplantation, chimeric mice
were treated with PBS or lactate to track live neutrophil mobilization over time.
Sca-1–eGFP transgenic mice were used to distinguish between Sca-1low sinusoidal
BMECs (sBMECs) from Sca-1+ arterial BMECs (aBMECs)24.
Intravital imaging by two-photon laser scanning microscopy. Chimeric mice
were anesthetized with a mixture of 50 mg ketamine, 15 mg xylazine and 2.5 mg
acepromazine per kg of body weight at the indicated time points after lactate or
PBS administration. Mice were mounted in a custom-designed heated mouse
holder and the skin above the calvaria was cut to reveal the underlying calvarial
bone. The mouse was immobilized to the heated holder, a drop of PBS was applied
to the skull, covered with a glass coverslip and placed under the microscope water-
dipping objective (Zeiss 20 × 1.05 NA plan objective). Zeiss LSM 880 upright
microscope fitted with Coherent Chameleon Vision laser was used. Images were
acquired with a femtosecond-pulsed two-photon laser tuned to 940 nm. The
microscope was fitted with a filter cube containing 565 LPXR to split the emission
to a PMT detector (with a 579–631 nm filter for tdTomato fluorescence) and to an
additional 505 LPXR mirror to further split the emission to two GaAsp detectors
(with a 500–550 nm filter for GFP fluorescence). For in vivo intravital imaging
experiments, images were acquired as 70–100 µm z-stacks with 3–5 µm steps
between each z-plane (15–19 frames) at 30 s interval for 30–50 min. Static images
were acquired as 30–100 µm z-stacks with 1–3 μm steps between each z-plane
(20–50 frames). The zoom was set to 0.7, and images were acquired at 512 × 512 x–
y resolution. Static images were acquired following mice scarification 4 h post
treatment. Sca-1 eGFP recipient mice reconstituted with Catchup donor BM (Ly6G
tdTomato) cells were used to endogenously label blood vessels (Sca-1 marker
distinguish between Sca-1low sinusoidal BMECs (sBMECs) from Sca-1+ arterial
BMECs (aBMECs)24) and neutrophils, respectively throughout all intravital ima-
ging experiments. The second harmonic generation (SHG) signal was used to
detect the inner bone surface (endosteum) and detect the BM cavities.
Quantification of the total volume of neutrophils inside the sinus. Quantifi-
cation of the total volume of neutrophils inside the sinus area over time was done
using Imaris software [v9.5.1, Bitplane AG], as followed: Neutrophils express Ly6G
tdTomato, while the sinusoidal- and arterial endothelial cells express Sac-1 eGFP
with different intensity (sinusoid: Sac-1low; arterials: Sca-1high 24). Sca-1 eGFP
signal is very bright and bleeds through into the tdTomato channel. To enable
detection of neutrophils only, first a new channel was generated by subtracting the
Sca-1 eGFP channel from the Ly6G tdTomato channel and then manually masking
the new channel in the sinus area using Imaris manual surface option. Imaris
Surface was used to segment neutrophils inside the sinus automatically (using local
contrast option, fix threshold, and discarding very small objects) and then mea-
sured their total volume for all time points.
In vivo EBD penetration to the BM. BM vascular endothelial barrier function was
assessed using the EBD assay. Evans Blue (Sigma) dissolved with PBS was filtered
and injected i.v. to mice. For the lactate, GPR81 agonist, Epac1 agonist, and LPS
treated mice; 20 mg/ml EBD was injected 4 h before mice were sacrificed. For
neutrophil depletion, the anti-Ly6G antibody was administered i.p. at 24 h prior to
EBD and LPS injections. In each experiment, a non-injected mouse was used for
control blank measurements. Subsequently, mice were perfused with PBS via the
left ventricle to remove the intravascular dye. Femurs were removed and for-
mamide was used for bone flushing, crushing and chopping. EBD was extracted in
formamide by incubation and shaking of flushed and crushed fractions, overnight
at 60 °C. After 30 min centrifugation at 2000g, EBD in BM supernatants was
quantitated by spectrophotometric analysis at 620 nm.
Immunofluorescence. Femurs fixed overnight at 4 °C in 4% paraformaldehyde
followed by 30% sucrose exchange for 2 days, were embedded in optimal cutting
temperature compound (Sakura Finetek USA, Inc., Tissue-Tek) and ‘snap-frozen’
in N-methylbutane chilled in liquid nitrogen. Sections of 8μm thickness were
generated with a cryostat (Leica) at −24 °C with a tungsten carbide blade (Leica)
and a CryoJane tape transfer system (Instrumedics). Sections were mounted on
adhesive-coated slides (Leica), fixed in acetone and air-dried. Sections were per-
meabilized with 0.1% Triton for 8 min, blocked in 20% normal horse serum
(Vector) and stained overnight at 4 °C with primary antibodies. Then sections were
incubated for 1 h with secondary antibodies and stained for 5 min in RT with
Hoechst33342 (Molecular Probes). Endomucin was stained using rat anti-mouse
Endomucin (1:50, clone V.7C7, Santa Cruz), followed by donkey anti-rat Alexa 488
(1:400, Jackson ImmunoResearch). Femoral sections from GPR81-RFP and WT
mice were stained with rabbit anti-mouse RFP (1:100, MBL), followed by donkey
anti-rabbit Rhodamin Red X conjugated antibody (1:200, Jackson
ImmunoResearch).
Confocal imaging was performed using an upright Leica TCS SP8, equipped
with internal Hybrid (HyD) detectors and Acusto Optical Tunable Filter (Leica
microsystems CMS GmbH, Germany). Excitation of Rhodamin Red X was done at
a wavelength of 561 nm by DPSS laser. Excitation of Alexa488 was done at a
wavelength of 488 nm by Argon laser. Excitation of Hoechst33342 was done by
Diode405 laser. Emission signal for Rhodamin Red X, Alexa488 and Hoechst was
collected using the HyD detectors at the range of 588–640, 497–555, and 413–501
nm, respectively. Images were acquired using the 8 k Hz resonant/galvometric
scanner in a 1024 × 1024 format using 20X air objective (HC PL APO 20×/0.75
CS2) and application zoom factor of 7 or 63× oil immersion objective (HC PL APO
63×/1.40 OIL CS2). Z stack acquisition was performed using 14 z steps while only
one slice was selected for presentation. The presented slice has pixel width 0.077
µm, pixel height 0.077 µm, and voxel depth 0.999 µm. The acquired images were
processed using ImageJ software to enhance the contrast.
Chemokine quantification in BM and plasma. CXCL1 and CXCL2 protein
amount were measured in BM samples. CXCL1, CXCL2, and G-CSF were mea-
sured in plasma samples taken 4 h post lactate injection using commercial ELISA
reagents, following the manufacturer’s protocol (R&D Systems). Total protein
content in BM fluids was quantified by Bradford assay. CXCL1/2 concentration in
the BM fluids was normalized per protein content.
Statistical analyses. All statistical analyses were conducted with Prism 8.0c ver-
sion (*p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, n.s. represents non-
significant). All data are expressed and presented as mean ± standard error of the
mean (s.e.m.) and all n numbers represent biological repeats. Unless indicated
otherwise in figure legends, a Student’s two-tailed unpaired t test was used to
determine the significance of the difference between means of two groups. One-
way ANOVA or two-way ANOVA was used to compare means among three or
more independent groups. Tukey or Bonferroni post hoc tests were used to
compare all pairs of treatment groups when the overall P value was <0.05. All
mutated or transgenic mice were assigned according to their genotype. Litter mates
and sex-matched animals were used whenever possible. All other parameters are
random. The authors were not blinded to allocation during experiments.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Data have been deposited in the GenBank (Gene Expression Omnibus; GEO) with the
accession code GSE143978. All other data are available within the manuscript and
Supplementary Information files and raw data are included as a Source Data file.
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